IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $604,000 | +106.1% | 40,657 | +46.6% | 0.06% | +123.1% |
| Q4 2021 | $293,000 | -41.0% | 27,730 | -41.7% | 0.03% | +8.3% |
| Q3 2021 | $497,000 | -56.1% | 47,543 | -40.1% | 0.02% | -59.3% |
| Q2 2021 | $1,133,000 | +102.0% | 79,308 | +25.3% | 0.06% | +55.3% |
| Q1 2021 | $561,000 | +9.1% | 63,281 | +54.1% | 0.04% | -54.8% |
| Q3 2020 | $514,000 | -60.7% | 41,061 | -5.8% | 0.08% | -61.5% |
| Q2 2020 | $1,307,000 | +1.5% | 43,594 | -13.7% | 0.22% | -26.4% |
| Q1 2020 | $1,288,000 | – | 50,497 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |